2022 Jun 02
Immune Therapy Targets Cells that Cause Leukemia Relapse
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the... Read more